Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to $16.0 million.

  • Genmab A's Depreciation & Amortization (CF) rose 2307.69% to $16.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $55.0 million, marking a year-over-year increase of 1224.49%. This contributed to the annual value of $16.0 million for FY2025, which is 4545.45% up from last year.
  • Latest data reveals that Genmab A reported Depreciation & Amortization (CF) of $16.0 million as of Q4 2025, which was up 2307.69% from $14.0 million recorded in Q3 2025.
  • Over the past 5 years, Genmab A's Depreciation & Amortization (CF) peaked at $16.0 million during Q4 2025, and registered a low of $11.0 million during Q1 2024.